webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Mc-Gly-Gly-Phe-Gly-PAB-OH TFA

  CAS No.:   Cat No.: BADC-01867 4.5  

Mc-Gly-Gly-Phe-Gly-PAB-OH TFA is a peptide-based cleavable ADC linker with Boc protection and trifluoroacetate salt, designed for enzyme-sensitive payload release and controlled conjugation in antibody-drug conjugates. Keywords: ADC linker, peptide linker, cleavable linker, TFA salt, payload release.

Mc-Gly-Gly-Phe-Gly-PAB-OH TFA

Structure of

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C34H39F3N6O10
Molecular Weight
748.70

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
Mc-GGFG-PAB-OH TFA
IUPAC Name
6-(2,5-dioxopyrrol-1-yl)-N-[2-[[2-[[(2S)-1-[[2-[4-(hydroxymethyl)anilino]-2-oxoethyl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]amino]-2-oxoethyl]hexanamide;2,2,2-trifluoroacetic acid
Canonical SMILES
C1=CC=C(C=C1)CC(C(=O)NCC(=O)NC2=CC=C(C=C2)CO)NC(=O)CNC(=O)CNC(=O)CCCCCN3C(=O)C=CC3=O.C(=O)(C(F)(F)F)O
InChI
InChI=1S/C32H38N6O8.C2HF3O2/c39-21-23-10-12-24(13-11-23)36-28(42)20-35-32(46)25(17-22-7-3-1-4-8-22)37-29(43)19-34-27(41)18-33-26(40)9-5-2-6-16-38-30(44)14-15-31(38)45;3-2(4,5)1(6)7/h1,3-4,7-8,10-15,25,39H,2,5-6,9,16-21H2,(H,33,40)(H,34,41)(H,35,46)(H,36,42)(H,37,43);(H,6,7)/t25-;/m0./s1
InChIKey
DOTXLPVUMXESLK-UQIIZPHYSA-N
Appearance
White to Off-white Solid

Mc-Gly-Gly-Phe-Gly-PAB-OH TFA, a peptide compound with a combination of glycine, phenylalanine, and p-aminobenzyl alcohol (PAB) residues, is widely utilized in scientific research due to its versatile applications in peptide synthesis and drug development. Its structure, which includes both amino acid sequences and a PAB group, is highly relevant in the design of peptide-based therapeutics, offering potential in a variety of biomedical fields.

One key application of Mc-Gly-Gly-Phe-Gly-PAB-OH TFA is in the realm of peptide drug development, where it serves as an important intermediate in the synthesis of peptide conjugates. The PAB group can be utilized for coupling reactions, enabling the attachment of various therapeutic molecules to the peptide backbone. This ability makes Mc-Gly-Gly-Phe-Gly-PAB-OH TFA a valuable tool for developing targeted drug delivery systems, improving the specificity and efficacy of treatments.

In addition, Mc-Gly-Gly-Phe-Gly-PAB-OH TFA is employed in the study of protein-protein interactions and enzymatic activity. The incorporation of phenylalanine in its sequence allows it to mimic protein structures, aiding in the identification and study of key biological pathways. Researchers can use it to model interactions between peptides and larger biomolecules, facilitating the understanding of molecular mechanisms in cellular processes. This function is particularly crucial in the development of novel inhibitors for various diseases.

Furthermore, Mc-Gly-Gly-Phe-Gly-PAB-OH TFA plays an important role in materials science, particularly in the synthesis of peptide-based materials with desirable properties such as biocompatibility and biodegradability. The incorporation of glycine and phenylalanine residues provides the compound with structural flexibility, while the PAB group enhances its reactivity, making it suitable for the creation of advanced biomaterials. This has applications in the fabrication of scaffolds for tissue engineering and other biomedical devices.

Finally, the use of Mc-Gly-Gly-Phe-Gly-PAB-OH TFA extends to peptide labeling and diagnostics, where it can be modified to attach to various detection molecules. This property is particularly beneficial for molecular imaging, offering insights into the distribution and localization of peptides in vivo. By modifying the compound with fluorescent or radiolabels, researchers can track peptide behaviors in biological systems, assisting in the development of new diagnostic tools and personalized medicine strategies.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: 1-BOC-Azetidine-3-carboxylic acid methyl ester | Mc-Gly-Gly-Phe-Gly-PAB-OH TFA
Send Inquiry
Verification code
Inquiry Basket